Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Genedata at SBI2 will Showcase How Genedata Screener Industrializes HCS

    Sep 14, 2015, 10:58 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Sep 14, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced it will be among the presenters at the 2nd Annual Society of Biomolecular Imaging and Informatics (SBI2) Meeting
    Full story
  • Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue

    Sep 14, 2015, 09:56 AM by Michael Croft
    Xconomy | Time to add one more recipient of crossover investor cash to the list of official IPO candidates. Cambridge, MA-based Dimension Therapeutics just filed for an IPO this morning to raise money to build gene therapies for rare diseases.
    Full story
  • Government Incentive Programs to Boost the E-Prescribing Market

    Sep 14, 2015, 05:37 AM by Michael Croft
    ALBANY, NY - Sep 14, 2015 - E-Prescribing is the system to broadcast information related to prescription among prescriber, dispenser, and pharmacy benefit manager electronically that allows a doctor and nurse to broadcast a new prescription electronically when any error in medication takes place at any stage in pharmacy operations
    Full story
  • Growing Dependence and Popularity of the Computational Biology Market

    Sep 14, 2015, 05:34 AM by Michael Croft
    ALBANY, NY - Sep 14, 2015 - Computational biology refers to the development of techniques for the collection, manipulation, and use of biological data to make discoveries and predictions
    Full story
  • Certara and Paidion Research Form Partnership Focused on Improving Pediatric Drug Development

    Sep 10, 2015, 08:35 AM by Michael Croft
    PRINCETON, NJ - Sep 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, and Paidion Research, Inc
    Full story
  • HudsonAlpha, Kailos Genetics, and a Plan for Population-Wide BRCA Screening

    Sep 9, 2015, 12:35 PM by Michael Croft
    Diagnostics World | In a large pilot initiative with little precedent, HudsonAlpha and its genetic testing spinoff Kailos plan to offer free or steeply discounted genetic screens for susceptibility to breast cancer to thousands of women in the area of Huntsville, Alabama, including women with no known risk factors for the disease.
    Full story
  • NIH Commits $49M to Fusion of Genomic Data and EHRs

    Sep 8, 2015, 14:30 PM by Michael Croft
    FierceBiotech | National Institutes of Health grants to 10 research teams, including at Brigham and Women's Hospital, Geisinger Health System, and the Mayo Clinic, will explore ways to use genomic data in patient care through integration with electronic health records.
    Full story
  • Google Launches Preemptible Virtual Machines, Cycle-Broad Case Study

    Sep 8, 2015, 09:00 AM by Michael Croft
    Bio-IT World | Google this morning has announced the general availability of the Google Cloud Platform’s Preemptible Virtual Machines, and Cycle Computing has detailed its first preemptible VM project: a cancer gene mapping project with the Broad Institute.
    Full story
  • Human Embryo's First Genetic Stirrings Felt

    Sep 4, 2015, 10:40 AM by Michael Croft
    GEN News | Researchers at the Karolinska Institutet have measured the RNA expression of pre-implantation fertilized embryos to learn which genes are activated in the first days of human development.
    Full story
  • Duke School of Medicine announces new Center for Statistical Genetics and Genomics

    Sep 3, 2015, 13:19 PM by Michael Croft
    Duke | The School of Medicine has launched the new Center for Statistical Genetics and Genomics.
    Full story
  • August News and Product Briefs

    Sep 3, 2015, 10:50 AM by Michael Croft
    Bio-IT World | News and product briefs from around the industry, including new types of data for the Genome in a Bottle Consortium and prizes for rare disease research.
    Full story
  • Microsoft bulks up Azure virtual machines

    Sep 3, 2015, 09:36 AM by Michael Croft
    Computerworld | The new Microsoft Azure GS-series virtual machines are made for demanding database-driven workloads.
    Full story
  • Intel Joins Up with Cancer Centers to Build Secure Networks for Patient Data Sharing

    Sep 2, 2015, 12:15 PM by Michael Croft
    Bio-IT World | The Collaborative Cancer Cloud, a collaborative effort of Intel, the Knight Cancer Center, and two additional partners, will be a secure, open source system for sending large queries between clinical data centers, making it possible to share data for research and patient care while minimizing the volume of data transferred and the associated patient privacy concerns.
    Full story
  • Thermo Fisher Clarifies Its Vision for Sequencing with Release of Ion S5 Instruments

    Sep 1, 2015, 13:25 PM by Michael Croft
    Bio-IT World | Thermo Fisher Scientific, which owns the Ion Torrent line of next-generation sequencing instruments, announced today that two new sequencers are being added to its portfolio, with a special emphasis on targeted sequencing in areas like oncology, rare disease, and gene expression.
    Full story
  • Rgenix Scores Rare Multimillion Dollar Funding Round for New York Biotech Scene

    Aug 31, 2015, 13:00 PM by Michael Croft
    Xconomy | The startup company has raised $8 million in new capital to develop drugs based on a discovery program that searches for targets by measuring microRNA expression in cancer.
    Full story
  • PrecisionFDA to Test Accuracy of Genomic Analysis Tools

    Aug 27, 2015, 14:25 PM by Michael Croft
    Bio-IT World | The FDA has contracted with DNAnexus to build an open web portal where researchers working on new genomic tests can evaluate their computational workflows, testing them on real and simulated DNA data and comparing them against industry standards.
    Full story
  • Florida Experience with Scripps Illustrates Difficulty of Building a Biotech Cluster from the Top Down

    Aug 26, 2015, 13:35 PM by Michael Croft
    Los Angeles Times | Jeb Bush's presidential run has brought renewed attention to one of the headline achievements of his tenure as governor of Florida: luring a new Scripps Research Institute campus to the state.
    Full story
  • White House Calls for Contributions to Precision Medicine Initiative

    Aug 25, 2015, 14:15 PM by Michael Croft
    HealthIT Analytics | White House Chief Data Scientist DJ Patil and Precision Medicine Initiative Project Manager Stephanie Devaney have issued a call for ideas to implement the national Precision Medicine Initiative, from new ways to engage patients to new APIs that make health data more accessible.
    Full story
  • Roche Buys Kapa to Boost Sequencing Technology Offering

    Aug 25, 2015, 14:00 PM by Michael Croft
    BioPharma Reporter | Roche has added technology to tailor enzymes for specific applications in next-generation DNA and RNA sequencing through the acquisition of Kapa Biosystems.
    Full story
  • Former Director of Clinical Pharmacology at CDER Appointed to Certara’s Simcyp Scientific Advisory Board

    Aug 21, 2015, 09:56 AM by Michael Croft
    PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J
    Full story
  • «
  • 361
  • 362
  • 363
  • 364 (current)
  • 365
  • 366
  • 367
  • 368
  • 369
  • 370
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy